Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-019948
Filing Date
2007-03-16
Accepted
2007-03-16 15:16:50
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-5925_110k.htm 10-K 2304569
2 EX-10.24 a07-5925_1ex10d24.htm EX-10.24 36355
3 EX-10.30 a07-5925_1ex10d30.htm EX-10.30 20579
4 EX-10.37 a07-5925_1ex10d37.htm EX-10.37 31719
5 EX-10.38 a07-5925_1ex10d38.htm EX-10.38 8376
6 EX-21 a07-5925_1ex21.htm EX-21 6209
7 EX-23.1 a07-5925_1ex23d1.htm EX-23.1 3149
8 EX-31.1 a07-5925_1ex31d1.htm EX-31.1 10267
9 EX-31.2 a07-5925_1ex31d2.htm EX-31.2 10697
10 EX-32.1 a07-5925_1ex32d1.htm EX-32.1 7502
  Complete submission text file 0001104659-07-019948.txt   2440808
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Filer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28308 | Film No.: 07699863
SIC: 2834 Pharmaceutical Preparations